Zumutor Biologics: Funding, Investors & Team (Oct 2026)
Zumutor is a biotechnology company focused on developing immuno-oncology therapies that harness the body's innate immune system to treat cancer. The company specializes in the discovery and development of therapeutic antibodies designed to activate natural killer (NK) cells and modulate the tumor microenvironment. Its proprietary INABLR® antibody discovery platform supports the identification and optimization of novel antibody candidates for oncology applications. Zumutor is advancing a pipeline of monoclonal antibody therapies, including ZM008, which targets immune checkpoint pathways involved in tumor immune evasion and is being evaluated for the treatment of solid tumors. In addition to its internal drug development programs, the company provides antibody discovery and development capabilities that support the creation of next-generation biologic therapies.
Zumutor Biologics has raised $7.3M across 1 funding round on record, the most recent a Series B of $7.3M announced in Jun 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Zumutor Biologics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Zumutor Biologics Funding Rounds
Zumutor Biologics Founders and Leadership Team
No contact details are on record for this team yet.
Zumutor Biologics Funding Compared to Other Biotechnology Startups
Zumutor Biologics' latest round of $7.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Zumutor Biologics in Biotechnology and Woburn
Companies Similar to Zumutor Biologics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Zumutor Biologics Funding FAQs
What does Zumutor Biologics do?
Zumutor is a biotechnology company focused on developing immuno-oncology therapies that harness the body's innate immune system to treat cancer. The company specializes in the discovery and development of therapeutic antibodies designed to activate natural killer (NK) cells and modulate the tumor microenvironment. Its proprietary INABLR® antibody discovery platform supports the identification and optimization of novel antibody candidates for oncology applications. Zumutor is advancing a pipeline of monoclonal antibody therapies, including ZM008, which targets immune checkpoint pathways involved in tumor immune evasion and is being evaluated for the treatment of solid tumors. In addition to its internal drug development programs, the company provides antibody discovery and development capabilities that support the creation of next-generation biologic therapies.
How much funding has Zumutor Biologics raised?
Zumutor Biologics has raised $7.3M across 1 round on record. The most recent is a Series B of $7.3M announced in Jun 2026.
When did Zumutor Biologics last raise funding?
Zumutor Biologics' most recent funding round on record is a Series B of $7.3M, announced in Jun 2026.
Who founded Zumutor Biologics?
FundedIQ lists Kavitha Iyer (Founder) at Zumutor Biologics.
Where is Zumutor Biologics headquartered?
Zumutor Biologics is based in Woburn, Massachusetts, United States.
How many employees does Zumutor Biologics have?
Zumutor Biologics is in the 11-50 employee band.
How does Zumutor Biologics' funding compare to other Biotechnology startups?
Zumutor Biologics' latest round of $7.3M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Zumutor Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zumutor Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.